|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 429 for Cblb

0.058s
Type Details Score
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1856223
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_14
Specimen Label: euxassay_012817_14
Detected: true
Specimen Num: 14
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1856223
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_15
Specimen Label: euxassay_012817_15
Detected: true
Specimen Num: 15
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1856223
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_16
Specimen Label: euxassay_012817_16
Detected: true
Specimen Num: 16
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1856223
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_17
Specimen Label: euxassay_012817_17
Detected: true
Specimen Num: 17
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1856223
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_18
Specimen Label: euxassay_012817_18
Detected: true
Specimen Num: 18
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1856223
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_19
Specimen Label: euxassay_012817_19
Detected: true
Specimen Num: 19
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1856223
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_20
Specimen Label: euxassay_012817_20
Detected: true
Specimen Num: 20
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1856223
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_21
Specimen Label: euxassay_012817_21
Detected: true
Specimen Num: 21
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1697723
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_08
Specimen Label: euxassay_012817_08
Detected: true
Specimen Num: 8
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1697723
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_09
Specimen Label: euxassay_012817_09
Detected: true
Specimen Num: 9
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1697723
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_10
Specimen Label: euxassay_012817_10
Detected: true
Specimen Num: 10
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1697723
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_11
Specimen Label: euxassay_012817_11
Detected: true
Specimen Num: 11
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1697723
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_12
Specimen Label: euxassay_012817_12
Detected: true
Specimen Num: 12
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1697723
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_13
Specimen Label: euxassay_012817_13
Detected: true
Specimen Num: 13
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1697723
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_14
Specimen Label: euxassay_012817_14
Detected: true
Specimen Num: 14
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1697723
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_15
Specimen Label: euxassay_012817_15
Detected: true
Specimen Num: 15
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1697723
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_16
Specimen Label: euxassay_012817_16
Detected: true
Specimen Num: 16
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1697723
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_17
Specimen Label: euxassay_012817_17
Detected: true
Specimen Num: 17
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1697723
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_18
Specimen Label: euxassay_012817_18
Detected: true
Specimen Num: 18
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1690623
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_11
Specimen Label: euxassay_012817_11
Detected: true
Specimen Num: 11
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1690623
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_14
Specimen Label: euxassay_012817_14
Detected: true
Specimen Num: 14
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1755823
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_09
Specimen Label: euxassay_012817_09
Detected: true
Specimen Num: 9
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1755823
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_12
Specimen Label: euxassay_012817_12
Detected: true
Specimen Num: 12
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1755823
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_13
Specimen Label: euxassay_012817_13
Detected: true
Specimen Num: 13
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1791823
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_09
Specimen Label: euxassay_012817_09
Detected: true
Specimen Num: 9
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1791823
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_10
Specimen Label: euxassay_012817_10
Detected: true
Specimen Num: 10
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1791823
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_13
Specimen Label: euxassay_012817_13
Detected: true
Specimen Num: 13
GXD Expression  
Probe: MGI:4425074
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1791823
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4823651
Age: embryonic day 14.5
Image: euxassay_012817_14
Specimen Label: euxassay_012817_14
Detected: true
Specimen Num: 14
Publication
First Author: Bhowmick S
Year: 2011
Journal: Int Immunol
Title: Antigen-specific splenic CD4+ and CD8+ regulatory T cells generated via the eye, suppress experimental autoimmune encephalomyelitis either at the priming or at the effector phase.
Volume: 23
Issue: 2
Pages: 119-28
Publication
First Author: Park IK
Year: 2017
Journal: Leukemia
Title: E3 ubiquitin ligase Cbl-b activates the p53 pathway by targeting Siva1, a negative regulator of ARF, in FLT3 inhibitor-resistant acute myeloid leukemia.
Volume: 31
Issue: 2
Pages: 502-505
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2001
Title: T31 Radiation Hybrid Data Curation in Mouse Genome Informatics
Publication
First Author: Zhang J
Year: 2002
Journal: J Immunol
Title: Cutting edge: regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination.
Volume: 169
Issue: 5
Pages: 2236-40
Publication
First Author: Sohn HW
Year: 2003
Journal: J Exp Med
Title: Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk.
Volume: 197
Issue: 11
Pages: 1511-24
Publication
First Author: Jeon MS
Year: 2004
Journal: Immunity
Title: Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction.
Volume: 21
Issue: 2
Pages: 167-77
Publication
First Author: Gruber T
Year: 2009
Journal: Sci Signal
Title: PKC-theta modulates the strength of T cell responses by targeting Cbl-b for ubiquitination and degradation.
Volume: 2
Issue: 76
Pages: ra30
Publication
First Author: Wohlfert EA
Year: 2006
Journal: J Immunol
Title: Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo.
Volume: 176
Issue: 3
Pages: 1316-20
Publication
First Author: McGargill MA
Year: 2004
Journal: Immunity
Title: A deficiency in Drak2 results in a T cell hypersensitivity and an unexpected resistance to autoimmunity.
Volume: 21
Issue: 6
Pages: 781-91
Publication
First Author: Gustin SE
Year: 2006
Journal: J Immunol
Title: Cbl-b is a negative regulator of inflammatory cytokines produced by IgE-activated mast cells.
Volume: 177
Issue: 9
Pages: 5980-9
Publication  
First Author: Adapala NS
Year: 2014
Journal: Bone
Title: Loss of Cbl-PI3K interaction in mice prevents significant bone loss following ovariectomy.
Volume: 67
Pages: 1-9
Publication
First Author: Naramura M
Year: 2002
Journal: Nat Immunol
Title: c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation.
Volume: 3
Issue: 12
Pages: 1192-9
Publication
First Author: An W
Year: 2015
Journal: Oncotarget
Title: Loss of Cbl and Cbl-b ubiquitin ligases abrogates hematopoietic stem cell quiescence and sensitizes leukemic disease to chemotherapy.
Volume: 6
Issue: 12
Pages: 10498-509
Publication
First Author: Pearce EL
Year: 2009
Journal: Nature
Title: Enhancing CD8 T-cell memory by modulating fatty acid metabolism.
Volume: 460
Issue: 7251
Pages: 103-7
Publication
First Author: Qiao G
Year: 2014
Journal: Cell Rep
Title: E3 ubiquitin ligase Cbl-b suppresses proallergic T cell development and allergic airway inflammation.
Volume: 6
Issue: 4
Pages: 709-23
Publication
First Author: Chiang JY
Year: 2007
Journal: J Clin Invest
Title: Ablation of Cbl-b provides protection against transplanted and spontaneous tumors.
Volume: 117
Issue: 4
Pages: 1029-36
Publication
First Author: Stromnes IM
Year: 2010
Journal: J Clin Invest
Title: Abrogating Cbl-b in effector CD8(+) T cells improves the efficacy of adoptive therapy of leukemia in mice.
Volume: 120
Issue: 10
Pages: 3722-34
Publication
First Author: Nakao R
Year: 2009
Journal: Mol Cell Biol
Title: Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading.
Volume: 29
Issue: 17
Pages: 4798-811
Publication
First Author: Guo H
Year: 2012
Journal: Cell Rep
Title: E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity.
Volume: 1
Issue: 5
Pages: 472-82
Publication
First Author: Qiao G
Year: 2007
Journal: J Immunol
Title: Negative regulation of CD40-mediated B cell responses by E3 ubiquitin ligase Casitas-B-lineage lymphoma protein-B.
Volume: 179
Issue: 7
Pages: 4473-9
Publication
First Author: Goetz B
Year: 2016
Journal: Oncotarget
Title: A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells.
Volume: 7
Issue: 32
Pages: 51107-51123
Publication  
First Author: Li X
Year: 2020
Journal: J Exp Med
Title: Cbl and Cbl-b control the germinal center reaction by facilitating naive B cell antigen processing.
Volume: 217
Issue: 9
Publication  
First Author: Zhang ZY
Year: 2020
Journal: Sci Signal
Title: Ubiquitination and functional modification of GluN2B subunit-containing NMDA receptors by Cbl-b in the spinal cord dorsal horn.
Volume: 13
Issue: 638
Publication
First Author: Krawczyk C
Year: 2000
Journal: Immunity
Title: Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells.
Volume: 13
Issue: 4
Pages: 463-73
Publication
First Author: Chiang YJ
Year: 2000
Journal: Nature
Title: Cbl-b regulates the CD28 dependence of T-cell activation.
Volume: 403
Issue: 6766
Pages: 216-20
Publication
First Author: Fang D
Year: 2001
Journal: Nat Immunol
Title: Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells.
Volume: 2
Issue: 9
Pages: 870-5
Publication
First Author: Mohapatra B
Year: 2017
Journal: Development
Title: An essential role of CBL and CBL-B ubiquitin ligases in mammary stem cell maintenance.
Volume: 144
Issue: 6
Pages: 1072-1086
Publication  
First Author: Tong H
Year: 2021
Journal: Front Immunol
Title: Ubiquitin Ligases CBL and CBL-B Maintain the Homeostasis and Immune Quiescence of Dendritic Cells.
Volume: 12
Pages: 757231
Publication
First Author: An W
Year: 2016
Journal: Oncotarget
Title: VAV1-Cre mediated hematopoietic deletion of CBL and CBL-B leads to JMML-like aggressive early-neonatal myeloproliferative disease.
Volume: 7
Issue: 37
Pages: 59006-59016
Publication
First Author: Kojo S
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: Mechanisms of NKT cell anergy induction involve Cbl-b-promoted monoubiquitination of CARMA1.
Volume: 106
Issue: 42
Pages: 17847-51
Publication
First Author: Zhang J
Year: 2004
Journal: J Immunol
Title: Inactivation of c-Cbl or Cbl-b differentially affects signaling from the high affinity IgE receptor.
Volume: 173
Issue: 3
Pages: 1811-8
Publication    
First Author: Brian BF 4th
Year: 2019
Journal: Elife
Title: Unique-region phosphorylation targets LynA for rapid degradation, tuning its expression and signaling in myeloid cells.
Volume: 8
Publication
First Author: McGargill MA
Year: 2008
Journal: J Immunol
Title: Drak2 regulates the survival of activated T cells and is required for organ-specific autoimmune disease.
Volume: 181
Issue: 11
Pages: 7593-605
Publication
First Author: Daniel JL
Year: 2010
Journal: J Biol Chem
Title: Cbl-b is a novel physiologic regulator of glycoprotein VI-dependent platelet activation.
Volume: 285
Issue: 23
Pages: 17282-91
Publication
First Author: Huang H
Year: 2010
Journal: Immunity
Title: K33-linked polyubiquitination of T cell receptor-zeta regulates proteolysis-independent T cell signaling.
Volume: 33
Issue: 1
Pages: 60-70
Publication
First Author: Krawczyk CM
Year: 2005
Journal: J Immunol
Title: Differential control of CD28-regulated in vivo immunity by the E3 ligase Cbl-b.
Volume: 174
Issue: 3
Pages: 1472-8
Publication
First Author: Raberger J
Year: 2008
Journal: Eur J Immunol
Title: Impaired T-cell development in the absence of Vav1 and Itk.
Volume: 38
Issue: 12
Pages: 3530-42
Publication
First Author: Hsu TS
Year: 2014
Journal: J Immunol
Title: Deltex1 promotes protein kinase Cθ degradation and sustains Casitas B-lineage lymphoma expression.
Volume: 193
Issue: 4
Pages: 1672-80
Publication
First Author: Li D
Year: 2004
Journal: J Immunol
Title: Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation.
Volume: 173
Issue: 12
Pages: 7135-9
Publication
First Author: Bhowmick S
Year: 2009
Journal: J Leukoc Biol
Title: The sympathetic nervous system modulates CD4(+)FoxP3(+) regulatory T cells via a TGF-beta-dependent mechanism.
Volume: 86
Issue: 6
Pages: 1275-83
Publication  
First Author: Choi YH
Year: 2015
Journal: Bone
Title: Cbl-b and c-Cbl negatively regulate osteoblast differentiation by enhancing ubiquitination and degradation of Osterix.
Volume: 75
Pages: 201-9
Publication
First Author: Zhu LL
Year: 2016
Journal: J Exp Med
Title: E3 ubiquitin ligase Cbl-b negatively regulates C-type lectin receptor-mediated antifungal innate immunity.
Volume: 213
Issue: 8
Pages: 1555-70
Publication
First Author: Schmid FM
Year: 2018
Journal: J Cell Biol
Title: IFT20 modulates ciliary PDGFRα signaling by regulating the stability of Cbl E3 ubiquitin ligases.
Volume: 217
Issue: 1
Pages: 151-161
Publication
First Author: Shen F
Year: 2007
Journal: Mol Biol Cell
Title: Activated Cdc42-associated kinase 1 is a component of EGF receptor signaling complex and regulates EGF receptor degradation.
Volume: 18
Issue: 3
Pages: 732-42
Publication
First Author: Carpino N
Year: 2004
Journal: Immunity
Title: Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2.
Volume: 20
Issue: 1
Pages: 37-46
Publication
First Author: Naramura M
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Rapidly fatal myeloproliferative disorders in mice with deletion of Casitas B-cell lymphoma (Cbl) and Cbl-b in hematopoietic stem cells.
Volume: 107
Issue: 37
Pages: 16274-9
Publication
First Author: Adams CO
Year: 2010
Journal: J Immunol
Title: Cbl-b(-/-) T cells demonstrate in vivo resistance to regulatory T cells but a context-dependent resistance to TGF-beta.
Volume: 185
Issue: 4
Pages: 2051-8
Publication  
First Author: Nguyen TTT
Year: 2021
Journal: J Exp Med
Title: Cbl-b deficiency prevents functional but not phenotypic T cell anergy.
Volume: 218
Issue: 7
Publication
First Author: Harada Y
Year: 2010
Journal: J Exp Med
Title: Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells.
Volume: 207
Issue: 7
Pages: 1381-91
Publication
First Author: Deepak V
Year: 2022
Journal: Proc Natl Acad Sci U S A
Title: IFT80 negatively regulates osteoclast differentiation via association with Cbl-b to disrupt TRAF6 stabilization and activation.
Volume: 119
Issue: 26
Pages: e2201490119
Publication
First Author: Han C
Year: 2010
Journal: Nat Immunol
Title: Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b.
Volume: 11
Issue: 8
Pages: 734-42
Publication
First Author: Yee NK
Year: 2013
Journal: Eur J Immunol
Title: β(2) integrins inhibit TLR responses by regulating NF-κB pathway and p38 MAPK activation.
Volume: 43
Issue: 3
Pages: 779-92
Publication
First Author: Badger-Brown KM
Year: 2013
Journal: Leukemia
Title: CBL-B is required for leukemogenesis mediated by BCR-ABL through negative regulation of bone marrow homing.
Volume: 27
Issue: 5
Pages: 1146-54
Publication  
First Author: Li X
Year: 2015
Journal: Elife
Title: Nur77 prevents excessive osteoclastogenesis by inducing ubiquitin ligase Cbl-b to mediate NFATc1 self-limitation.
Volume: 4
Pages: e07217
Publication
First Author: Zhang W
Year: 2003
Journal: J Biol Chem
Title: Negative regulation of T cell antigen receptor-mediated Crk-L-C3G signaling and cell adhesion by Cbl-b.
Volume: 278
Issue: 26
Pages: 23978-83
Publication
First Author: Feng Q
Year: 2006
Journal: Nat Cell Biol
Title: Cool-1 functions as an essential regulatory node for EGF receptor- and Src-mediated cell growth.
Volume: 8
Issue: 9
Pages: 945-56
Publication
First Author: Purev E
Year: 2009
Journal: Mol Biol Cell
Title: c-Cbl and Cbl-b act redundantly to protect osteoclasts from apoptosis and to displace HDAC6 from beta-tubulin, stabilizing microtubules and podosomes.
Volume: 20
Issue: 18
Pages: 4021-30
Publication
First Author: Bachmaier K
Year: 2000
Journal: Nature
Title: Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b.
Volume: 403
Issue: 6766
Pages: 211-6
Publication
First Author: Qiao G
Year: 2008
Journal: Mol Cell Biol
Title: T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b.
Volume: 28
Issue: 7
Pages: 2470-80
Publication
First Author: Huang F
Year: 2006
Journal: Immunity
Title: Establishment of the major compatibility complex-dependent development of CD4+ and CD8+ T cells by the Cbl family proteins.
Volume: 25
Issue: 4
Pages: 571-81
Publication
First Author: Adapala NS
Year: 2014
Journal: J Cell Biochem
Title: Loss of Cbl-PI3K interaction enhances osteoclast survival due to p21-Ras mediated PI3K activation independent of Cbl-b.
Volume: 115
Issue: 7
Pages: 1277-89
Publication
First Author: Tran CW
Year: 2017
Journal: J Immunol
Title: Glycogen Synthase Kinase-3 Modulates Cbl-b and Constrains T Cell Activation.
Volume: 199
Issue: 12
Pages: 4056-4065
Publication
First Author: Li X
Year: 2018
Journal: Immunity
Title: Cbl Ubiquitin Ligases Control B Cell Exit from the Germinal-Center Reaction.
Volume: 48
Issue: 3
Pages: 530-541.e6
Publication
First Author: Kitaura Y
Year: 2007
Journal: Immunity
Title: Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b.
Volume: 26
Issue: 5
Pages: 567-78
Publication
First Author: Xiao Y
Year: 2015
Journal: J Immunol
Title: Protein Tyrosine Phosphatase SHP-1 Modulates T Cell Responses by Controlling Cbl-b Degradation.
Volume: 195
Issue: 9
Pages: 4218-27
Publication
First Author: Wilson BG
Year: 2010
Journal: Cancer Cell
Title: Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation.
Volume: 18
Issue: 4
Pages: 316-28
Publication  
First Author: Cho JH
Year: 2016
Journal: Nat Commun
Title: CD45-mediated control of TCR tuning in naïve and memory CD8+ T cells.
Volume: 7
Pages: 13373
Publication
First Author: Choi EY
Year: 2008
Journal: Blood
Title: Regulation of LFA-1-dependent inflammatory cell recruitment by Cbl-b and 14-3-3 proteins.
Volume: 111
Issue: 7
Pages: 3607-14
Publication
First Author: Qiao G
Year: 2013
Journal: J Immunol
Title: T cell activation threshold regulated by E3 ubiquitin ligase Cbl-b determines fate of inducible regulatory T cells.
Volume: 191
Issue: 2
Pages: 632-9
Publication
First Author: Teh CE
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: T-cell regulation by casitas B-lineage lymphoma (Cblb) is a critical failsafe against autoimmune disease due to autoimmune regulator (Aire) deficiency.
Volume: 107
Issue: 33
Pages: 14709-14
Publication
First Author: Kim JH
Year: 2010
Journal: J Biol Chem
Title: Negative feedback control of osteoclast formation through ubiquitin-mediated down-regulation of NFATc1.
Volume: 285
Issue: 8
Pages: 5224-31
Publication
First Author: Baguet A
Year: 2004
Journal: J Exp Med
Title: A Leishmania major response locus identified by interval-specific congenic mapping of a T helper type 2 cell bias-controlling quantitative trait locus.
Volume: 200
Issue: 12
Pages: 1605-12